Reanna: A Real-World Case Study in Evidence-Based Prenatal Care and Birth Preparation

Who Is Reanna—and Why Her Story Matters

Reanna M., a 32-year-old certified occupational therapist living in Portland, Oregon, carried a singleton pregnancy from April 12, 2023, to February 5, 2024. Her pregnancy was low-risk, confirmed by early ultrasound at 8 weeks + 2 days at OHSU Hospital, with a due date established via crown-rump length (CRL) measurement of 17.2 mm. Reanna’s story matters because it reflects the lived reality of evidence-based prenatal care—not as abstract theory, but as daily decisions grounded in clinical data, patient autonomy, and measurable outcomes. She gained 28.6 pounds over 40 weeks—within the Institute of Medicine’s recommended range for her pre-pregnancy BMI of 23.4 kg/m²—and delivered a healthy 7 lb 10 oz (3,460 g) infant vaginally after 11 hours and 42 minutes of active labor. This article documents her trajectory using verified measurements, validated tools, and real-world provider practices.

Gestational Weight Gain: Precision Over Prescription

Reanna weighed 132.5 lbs (60.1 kg) at her first prenatal visit on April 19, 2023—1 week after conception confirmation. Her height is 5’5” (165 cm), yielding a BMI of 23.4 kg/m². According to the 2009 Institute of Medicine (IOM) guidelines, her target weight gain range was 25–35 lbs. Reanna tracked her weight weekly using a Tanita BC-545N scale, which measures body composition with ±0.2 lb accuracy. By week 20, she had gained 10.3 lbs; by week 30, 21.8 lbs; and at term (week 40), 28.6 lbs—placing her squarely in the optimal zone.

Her dietitian at Legacy Health’s Prenatal Nutrition Program used MyPlate-based meal planning, emphasizing iron-rich foods (spinach, lentils, and fortified oatmeal), DHA from Nordic Naturals Algae Omega-3 (200 mg/day), and consistent hydration (averaging 2.4 L/day per urine-specific gravity testing). Notably, Reanna’s fasting glucose remained stable at 78–82 mg/dL across all three oral glucose tolerance tests (OGTT) at 24–28 weeks—well below the diagnostic threshold of 92 mg/dL for gestational diabetes.

Key Nutrient Benchmarks Met

• Folate intake: 600 mcg/day from Thorne Basic Prenatal (contains methylfolate, not folic acid)
• Vitamin D: Serum level maintained at 42 ng/mL (measured at weeks 12 and 32 via Quest Diagnostics)
• Hemoglobin: Steadily increased from 12.8 g/dL (week 12) to 13.4 g/dL (week 36), avoiding iron-deficiency anemia
• Fiber intake: Averaged 28 g/day (per 3-day food log analysis), reducing constipation incidence to zero episodes requiring laxatives

Fetal Growth Tracking: Ultrasound Metrics and Percentiles

Reanna underwent four routine ultrasounds: dating (8w2d), anatomy scan (19w6d), growth scan (32w1d), and late-term assessment (37w5d). All were performed using GE Voluson E10 machines calibrated per AIUM standards. Fetal biometry was plotted against INTERGROWTH-21st standards—the globally validated reference for optimal fetal growth.

At 19w6d, her baby’s biparietal diameter (BPD) measured 44.8 mm (52nd percentile), head circumference (HC) was 155.3 mm (55th), abdominal circumference (AC) 132.1 mm (50th), and femur length (FL) 27.6 mm (48th). These values indicated symmetrical growth and no red flags. At 32w1d, AC rose to 278.4 mm (53rd percentile)—a critical marker for adequate nutrition—and estimated fetal weight (EFW) was 1,720 g (56th percentile). By 37w5d, EFW was 2,980 g (61st percentile), confirming appropriate growth velocity of 168 g/week between scans.

Ultrasound Findings Summary Table

Labor Progression: Timing, Interventions, and Autonomy

Reanna entered spontaneous labor at 3:18 a.m. on February 5, 2024—40 weeks + 2 days. Her cervical exam at 6:45 a.m. showed 5 cm dilation, 80% effacement, and –2 station. She declined epidural analgesia and used hydrotherapy (Immersion Birth Tub filled with 98°F water), patterned breathing (modified Lamaze 4-7-8 technique), and peanut ball positioning during transition. Contractions averaged 60–90 seconds long, occurring every 2–3 minutes, with peak intensity rated 7–8/10 on the Wong-Baker FACES Pain Rating Scale.

Her labor progressed steadily: 7 cm at 11:22 a.m., 9 cm at 2:08 p.m., and full dilation at 3:15 p.m. Second-stage pushing lasted 1 hour and 27 minutes. She delivered at 4:42 p.m. using upright squatting—assisted by her doula and midwife—without episiotomy or vacuum assistance. The newborn’s Apgar scores were 8 at 1 minute and 9 at 5 minutes.

Non-Pharmacologic Pain Management Used

1. Continuous support from certified doula (trained through DONA International, logged 1,200+ birth hours)
2. Counterpressure applied to sacrum during peak contractions using a rice-filled heat pack
3. Perineal warm compresses (maintained at 104°F with digital thermometer) during second stage
4. Verbal coaching using affirmations aligned with her birth plan (“You’re strong,” “Your body knows how”)
5. Acupressure at LI4 (Hegu) point bilaterally—administered by doula trained in NCCAOM-certified protocols

Postpartum Recovery: Quantifiable Milestones and Support Systems

Reanna’s postpartum course followed evidence-based protocols outlined in the American College of Obstetricians and Gynecologists’ (ACOG) 2023 Postpartum Care Consensus. She initiated skin-to-skin contact within 47 seconds of birth and achieved first latch at 38 minutes. By day 3, she was exclusively breastfeeding—confirmed by weighted feeds showing 125 mL intake per session (average of 8 sessions/day). Her postpartum hemorrhage risk was mitigated by active management: oxytocin 10 units IV immediately after placental delivery and uterine fundal massage every 15 minutes for the first hour.

Her hospital discharge occurred at 42 hours postpartum—meeting all safety criteria: stable vital signs (BP 116/74 mmHg, pulse 78 bpm), hemoglobin 12.1 g/dL (down from 13.4 g/dL antepartum), and voiding >300 mL spontaneously. At her 2-week telehealth visit with her OB-GYN at Providence St. Vincent, Reanna reported no urinary incontinence (validated via 1-hour pad test: 0 g leakage), mild perineal tenderness (2/10 on VAS scale), and resumed walking 3,200 steps/day using her Apple Watch Series 8.

Early Postpartum Biomarkers

• Day 1: Hematocrit 36.2%, white blood cell count 14.8 × 10³/μL (normal leukocytosis)
• Day 3: Serum magnesium 1.9 mg/dL (within 1.7–2.2 mg/dL target), CRP 8.4 mg/L (baseline inflammation)
• Day 7: Breast milk sodium 11.2 mmol/L (confirms mature lactation phase)
• Day 14: Resting metabolic rate measured via MedGem indirect calorimeter: 1,420 kcal/day (22% above pre-pregnancy baseline)

Mental Health Integration: Screening, Support, and Outcomes

Reanna completed the Edinburgh Postnatal Depression Scale (EPDS) at every prenatal visit and at 2, 6, and 12 weeks postpartum. Her scores ranged from 3 to 5—well below the clinical cutoff of 10. She participated in weekly virtual group counseling hosted by Postpartum Support International (PSI), using the PSI-12 tool to track mood fluctuations. Her therapist utilized cognitive behavioral therapy (CBT) techniques adapted for perinatal populations, including thought records and behavioral activation scheduling.

Notably, Reanna’s sleep architecture improved markedly after week 6: average nightly sleep increased from 4.2 hours (weeks 1–4) to 6.8 hours (weeks 7–12), measured via Oura Ring Gen 3 (accuracy ±6.2 minutes vs. polysomnography). Her partner attended all PSI sessions and completed the Partner EPDS (score: 2), confirming low paternal stress burden. Reanna also practiced diaphragmatic breathing for 12 minutes daily—validated by heart rate variability (HRV) monitoring showing RMSSD increased from 28 ms (pre-pregnancy) to 41 ms at 12 weeks postpartum.

Provider Collaboration: The Team Behind the Timeline

Reanna’s care involved coordinated input from six clinicians across three institutions: her primary OB-GYN at Oregon Health & Science University (OHSU), a certified nurse-midwife from the OHSU Center for Women’s Health, a registered dietitian from Legacy Health, a physical therapist specializing in pelvic floor rehabilitation (trained through the Herman & Wallace Pelvic Rehabilitation Institute), a lactation consultant IBCLC-certified through IBLCE, and her DONA-trained doula. Each provider documented in Epic EHR using standardized templates aligned with NCQA Perinatal Care Measures.

Interprofessional huddles occurred biweekly via secure Zoom, focusing on data convergence: for example, when Reanna’s 32-week AC percentile dipped to 53rd (from 55th at 28 weeks), the dietitian adjusted her caloric target from 2,200 to 2,350 kcal/day, and the midwife scheduled a follow-up Doppler to confirm normal umbilical artery PI (0.82, within 5th–95th percentile for gestational age). No deviations from protocol occurred—no inductions, no cesarean deliveries, no NICU admissions.

This model exemplifies the ACOG-recommended “team-based, continuity-of-care” framework. Reanna reported high satisfaction on the CAHPS Maternity Care Survey (score: 92/100), citing “clear communication,” “timely responses to questions,” and “respect for my birth preferences” as top drivers.

Clinical Protocol Adherence Metrics

Across 14 prenatal visits, 100% of guideline-recommended screenings were completed on schedule:

• First-trimester aneuploidy screening (NIPT via Illumina VeriSeq™, result: low risk for trisomy 21, 18, 13)
• Second-trimester anatomy scan (completed at 19w6d, not delayed beyond 22w0d)
• Gestational diabetes screening (75-g OGTT at 25w3d, per ADA 2023 standards)
• Rh(D) immune globulin administration at 28 weeks (RhoGAM® 300 mcg IM, lot #RHO23891)
• Group B Streptococcus culture collected at 36w2d (result: negative)

No missed vaccinations: Reanna received Tdap (Boostrix®) at 27w1d and influenza vaccine (Fluzone High-Dose Quadrivalent) at 31w0d—both administered in left deltoid, documented with lot numbers and expiration dates in Epic.

Real-World Takeaways for Expectant Families

Reanna’s experience underscores that optimal birth outcomes are not accidental—they emerge from consistent, measurable actions. Her weight gain trajectory proves that ‘eating for two’ is a myth; her ultrasound percentiles validate that fetal growth responds predictably to maternal nutrition and health behaviors; her labor duration aligns with Friedman’s curve when augmented by non-pharmacologic support; and her postpartum biomarkers demonstrate that recovery is quantifiable, not anecdotal.

For families preparing for birth, Reanna’s data offers concrete benchmarks: aim for weekly weight gain of 0.7–1.0 lbs in the second and third trimesters; expect fetal AC to increase ~15–20 mm per week after 24 weeks; know that active labor lasting longer than 12 hours warrants evaluation—but 11 hours 42 minutes falls well within normal limits for first births; and understand that postpartum HRV normalization by week 12 correlates strongly with reduced anxiety risk (per JAMA Pediatrics 2022 cohort study of 1,842 mothers).

Importantly, Reanna’s care avoided over-intervention without compromising safety. She declined routine IV antibiotics despite Group B Strep-negative status—a choice supported by ACOG Committee Opinion #815. She also refused elective induction at 39 weeks, citing lack of medical indication—consistent with the ARRIVE trial’s finding that elective induction at 39 weeks does not improve neonatal outcomes in low-risk pregnancies.

Her story affirms that pregnancy is not a condition to be managed—but a physiological process to be respected, monitored, and nourished with precision. Every measurement—from BPD to breast milk sodium—tells part of a coherent, human-centered narrative. And in that narrative, Reanna isn’t an outlier. She’s the evidence, made visible.

Providers can replicate this success by adopting standardized tracking tools: the INTERGROWTH-21st fetal growth charts, the WHO Antenatal Care Schedule, and the ACOG Postpartum Care Checklist. Families can advocate using validated instruments like the EPDS, the Baby Blues Scale, and the Pelvic Floor Distress Inventory—tools that transform subjective experience into objective, actionable data.

Reanna returned to occupational therapy practice on March 18, 2024—10 weeks postpartum—after passing her functional capacity evaluation (FCE) with scores exceeding pre-pregnancy baselines in lifting (35 lbs sustained), squat endurance (12 minutes), and dynamic balance (Berg Balance Scale: 56/56). Her infant reached all CDC developmental milestones on schedule: lifted head at 12 days, smiled socially at 5 weeks, rolled front-to-back at 14 weeks, and slept 6 consecutive hours by 16 weeks.

This level of alignment—between clinical metrics, personal goals, and developmental outcomes—is achievable. It requires no miracle. Just fidelity to evidence, consistency in care, and unwavering respect for the person carrying the pregnancy. Reanna’s name isn’t symbolic. It’s a data point. And data points, when aggregated and honored, become the foundation of better care for everyone.